§ BIOTECHNOLOGY
USD · Biotechnology

MNKD

MANNKIND CORP
USDSector · BiotechnologyMarket cap · $0MBeta · 1.06
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
136 increased/new, 71 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/E144.9P/B4.03
EPS (TTM)0.02
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
State Street18.7M0.0%+28%
BlackRock, Inc.13.2M0.0%−1%
VANGUARD CAPITAL MANAGEMENT LLC12.9M0.0%n/a
VANGUARD CAPITAL MANAGEMENT LLC12.9M0.0%n/a
BlackRock, Inc.10.2M0.0%n/a
UBS Group AG8.1M0.0%+62%
AC INTELLIGENCE

Top institutional owners for MNKD as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER79.3% · 0 holders
OTHER8.4% · 175 holders
DEALER / BANK4.8% · 25 holders
PASSIVE / INDEX4.4% · 10 holders
QUALITY / COMPOUNDER1.5% · 17 holders
TACTICAL / MACRO0.9% · 4 holders
SYSTEMATIC / QUANT0.4% · 6 holders
INCOME / DEFENSIVE0.2% · 15 holders
GROWTH / MOMENTUM0.1% · 1 holder
AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
AC INTELLIGENCE

No Form 4 filings on record for MNKD in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention MNKD yet.